Monoclonal antibody of 100 μg targeting Integrin β1 for FCM, IPP, WB.
| Product Specifications | |
| Application | FC, IP, WB |
| Reactivity | Human |
| Clonality | Monoclonal IgG1 |
| Host | Mouse |
| Immunogen | G-361 (human melanoma cells) |
| Gene ID - Human | |
| Gene ID - Mouse | |
| Formulation | This antibody is lyophilized form. Prepare a stock solution by dissolving the lyophilized antibody in 100 mL of distilled water. After reconstitution, the IgG concentration shoµld be 1 mg/mL in PBS (pH 7.2) /1% sucrose. No preservative is contained. |
| Citations for Anti-CD29 (Integrinβ1) (Human) mAb (Clone: AG89) – 2 Found |
| Fujita, Motomichi; Ito-Fujita, Yuka; Iyoda, Takuya; Sasada, Manabu; Okada, Yuko; Ishibashi, Kazuma; Osawa, Takuro; Kodama, Hiroaki; Fukai, Fumio; Suzuki, Hideo. Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via β1-Integrin Activation in Fibroblasts. International Journal Of Molecular Sciences. 2019;20(11) PubMed - Comments: Used in: FCM |
| Sasada, Manabu; Iyoda, Takuya; Asayama, Tatsufumi; Suenaga, Yusuke; Sakai, Shunsuke; Kase, Naoya; Kodama, Hiroaki; Yokoi, Sana; Isohama, Yoichiro; Fukai, Fumio. Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins. Oncotarget. 2019;10(48):4960-4972. PubMed - Comments: Used in: FCM |